Stockscreener 앱 받기
3.76
2.17%
0.08
시간 외 거래:
3.76
전일 마감가:
$3.68
열려 있는:
$3.7
하루 거래량:
1.19M
Relative Volume:
0.81
시가총액:
$545.29M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-4.1755
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
+3.87%
1개월 성능:
+10.26%
6개월 성능:
+69.37%
1년 성능:
-28.92%
1일 변동 폭
$3.62
$3.78
1주일 범위
$3.37
$3.80
52주 변동 폭
$1.665
$6.21
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.76 | 533.68M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Is Maravai LifeSciences Holdings Inc. (MAR) stock undervalued at current priceMarket Weekly Review & AI Driven Price Predictions - newser.com
Published on: 2025-11-21 05:22:01 - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform value stocksQuarterly Market Review & Accurate Buy Signal Notifications - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Maravai LifeSciences Holdings Inc. stock a top pick in earnings seasonJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. (MAR) stock a good hedge against inflationEarnings Recap Report & Daily Growth Stock Tips - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock is a must watch tickerPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact Maravai LifeSciences Holdings Inc. (MAR) stockJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. (MAR) stock suitable for passive index fundsSell Signal & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 14:21:53 - newser.com
Why Maravai LifeSciences Holdings Inc. stock appeals to dividend seekersTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure bill2025 Trade Ideas & Weekly Momentum Picks - newser.com
Adversity is less terrifying than hope: Maravai LifeSciences Holdings Inc (MRVI) - Setenews
Maravai Lifesciences at Jefferies: Strategic Restructuring Focus By Investing.com - Investing.com Canada
Is Maravai LifeSciences Holdings Inc. stock a bargain at current levelsWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Market Risk Report & Reliable Price Breakout Signals - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI.MX) Company Profile & Facts - Yahoo! Finance Canada
Why Maravai LifeSciences Holdings Inc. stock remains on watchlistsJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai Lifesciences CEO Increases Stake with Significant Share Purchase (MRVI) - GuruFocus
Maravai Lifesciences Holdings Insider Bought Shares Worth $702,689, According to a Recent SEC Filing - MarketScreener
How Analyst Views on Maravai LifeSciences Are Shifting as the Story Evolves - Yahoo Finance
Goldman Sachs Downgrades Maravai LifeSciences Holdings (MRVI) - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025Share Buyback & Real-Time Volume Spike Alerts - newser.com
Why Maravai LifeSciences Holdings Inc. stock remains resilientJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
마라바이 라이프 주식 (MRVI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Brust Bernd | Chief Executive Officer |
Nov 11 '25 |
Buy |
3.24 |
157,201 |
509,331 |
157,201 |
| Brust Bernd | Chief Executive Officer |
Nov 12 '25 |
Buy |
3.21 |
93,358 |
299,679 |
250,559 |
| ORESHACK KURT | General Counsel |
Jan 31 '25 |
Sale |
5.03 |
25,000 |
125,750 |
167,618 |
0.53%
1.88%
자본화:
|
볼륨(24시간):